Market revenue in 2022 | USD 572.1 million |
Market revenue in 2030 | USD 495.1 million |
Growth rate | -1.8% (CAGR from 2022 to 2030) |
Largest segment | Hiv |
Fastest growing segment | Herpes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | HIV, Hepatitis, Herpes, Influenza |
Key market players worldwide | Roche Holding AG, GSK PLC ADR, AbbVie Inc, Merck & Co Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Dr Reddy's Laboratories Ltd ADR, Aurobindo Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiviral drugs market will help companies and investors design strategic landscapes.
Hiv was the largest segment with a revenue share of 34.33% in 2022. Horizon Databook has segmented the Argentina antiviral drugs market based on hiv, hepatitis, herpes, influenza covering the revenue growth of each sub-segment from 2018 to 2030.
Government support to improve the healthcare system and facilitate access to advanced diagnosis & treatment is expected to fuel the market growth in Argentina. However, the limited affordability of treatment and low diagnosis rate of herpes in the country may hamper market growth during the forecast period.
Constant developments like geographic expansion and new product launches have contributed to Argentina’s market growth. In addition, pharmaceutical production in Argentina is dominated by local businesses.
Only Sanofi and Bayer, two of the top 10 pharmaceutical companies operating in Argentina, are foreign multinational companies operating in the country. This sector has a considerable degree of saturation, with roughly 20 laboratories accounting for 70% of the total revenue.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina antiviral drugs market , including forecasts for subscribers. This country databook contains high-level insights into Argentina antiviral drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account